chr12-43786492-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_016123.4(IRAK4):​c.1282G>A​(p.Ala428Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.104 in 1,612,510 control chromosomes in the GnomAD database, including 10,368 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 2177 hom., cov: 32)
Exomes 𝑓: 0.10 ( 8191 hom. )

Consequence

IRAK4
NM_016123.4 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.863

Publications

58 publications found
Variant links:
Genes affected
IRAK4 (HGNC:17967): (interleukin 1 receptor associated kinase 4) This gene encodes a kinase that activates NF-kappaB in both the Toll-like receptor (TLR) and T-cell receptor (TCR) signaling pathways. The protein is essential for most innate immune responses. Mutations in this gene result in IRAK4 deficiency and recurrent invasive pneumococcal disease. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
IRAK4 Gene-Disease associations (from GenCC):
  • immunodeficiency 67
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0038244724).
BP6
Variant 12-43786492-G-A is Benign according to our data. Variant chr12-43786492-G-A is described in ClinVar as Benign. ClinVar VariationId is 308732.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.268 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_016123.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IRAK4
NM_016123.4
MANE Select
c.1282G>Ap.Ala428Thr
missense
Exon 11 of 12NP_057207.2
IRAK4
NM_001114182.3
c.1282G>Ap.Ala428Thr
missense
Exon 12 of 13NP_001107654.1
IRAK4
NM_001351345.2
c.1282G>Ap.Ala428Thr
missense
Exon 12 of 13NP_001338274.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IRAK4
ENST00000613694.5
TSL:1 MANE Select
c.1282G>Ap.Ala428Thr
missense
Exon 11 of 12ENSP00000479889.3
IRAK4
ENST00000551736.5
TSL:1
c.1282G>Ap.Ala428Thr
missense
Exon 12 of 13ENSP00000446490.1
IRAK4
ENST00000547101.5
TSL:1
n.*1184G>A
non_coding_transcript_exon
Exon 12 of 13ENSP00000449317.1

Frequencies

GnomAD3 genomes
AF:
0.147
AC:
22324
AN:
151884
Hom.:
2164
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.271
Gnomad AMI
AF:
0.0406
Gnomad AMR
AF:
0.140
Gnomad ASJ
AF:
0.155
Gnomad EAS
AF:
0.105
Gnomad SAS
AF:
0.117
Gnomad FIN
AF:
0.0607
Gnomad MID
AF:
0.187
Gnomad NFE
AF:
0.0921
Gnomad OTH
AF:
0.156
GnomAD2 exomes
AF:
0.114
AC:
28505
AN:
250834
AF XY:
0.109
show subpopulations
Gnomad AFR exome
AF:
0.271
Gnomad AMR exome
AF:
0.131
Gnomad ASJ exome
AF:
0.157
Gnomad EAS exome
AF:
0.113
Gnomad FIN exome
AF:
0.0630
Gnomad NFE exome
AF:
0.0932
Gnomad OTH exome
AF:
0.112
GnomAD4 exome
AF:
0.0996
AC:
145462
AN:
1460508
Hom.:
8191
Cov.:
31
AF XY:
0.0990
AC XY:
71950
AN XY:
726566
show subpopulations
African (AFR)
AF:
0.279
AC:
9331
AN:
33402
American (AMR)
AF:
0.134
AC:
5965
AN:
44634
Ashkenazi Jewish (ASJ)
AF:
0.159
AC:
4150
AN:
26100
East Asian (EAS)
AF:
0.0898
AC:
3556
AN:
39598
South Asian (SAS)
AF:
0.106
AC:
9128
AN:
86028
European-Finnish (FIN)
AF:
0.0670
AC:
3576
AN:
53394
Middle Eastern (MID)
AF:
0.167
AC:
963
AN:
5758
European-Non Finnish (NFE)
AF:
0.0916
AC:
101764
AN:
1111264
Other (OTH)
AF:
0.117
AC:
7029
AN:
60330
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
6634
13267
19901
26534
33168
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3938
7876
11814
15752
19690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.147
AC:
22362
AN:
152002
Hom.:
2177
Cov.:
32
AF XY:
0.144
AC XY:
10706
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.272
AC:
11271
AN:
41444
American (AMR)
AF:
0.140
AC:
2132
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.155
AC:
538
AN:
3466
East Asian (EAS)
AF:
0.105
AC:
542
AN:
5170
South Asian (SAS)
AF:
0.117
AC:
563
AN:
4830
European-Finnish (FIN)
AF:
0.0607
AC:
639
AN:
10526
Middle Eastern (MID)
AF:
0.190
AC:
56
AN:
294
European-Non Finnish (NFE)
AF:
0.0921
AC:
6260
AN:
67990
Other (OTH)
AF:
0.154
AC:
324
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
909
1818
2727
3636
4545
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
238
476
714
952
1190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.112
Hom.:
5256
Bravo
AF:
0.158
TwinsUK
AF:
0.0841
AC:
312
ALSPAC
AF:
0.0931
AC:
359
ESP6500AA
AF:
0.272
AC:
1200
ESP6500EA
AF:
0.0986
AC:
847
ExAC
AF:
0.115
AC:
13993
Asia WGS
AF:
0.126
AC:
437
AN:
3476
EpiCase
AF:
0.0955
EpiControl
AF:
0.0975

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 1 paper claims increased risk of gram positive infection

Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 27% of patients studied by a panel of primary immunodeficiencies. Number of patients: 26. Only high quality variants are reported.

Immunodeficiency 67 Benign:2
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 21576904)

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.69
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
8.2
DANN
Benign
0.62
DEOGEN2
Benign
0.17
T
Eigen
Benign
-0.74
Eigen_PC
Benign
-0.66
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.62
T
MetaRNN
Benign
0.0038
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.2
L
PhyloP100
0.86
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.47
N
REVEL
Benign
0.056
Sift
Benign
0.62
T
Sift4G
Benign
0.56
T
Polyphen
0.0
B
Vest4
0.028
ClinPred
0.0026
T
GERP RS
-0.29
Varity_R
0.060
gMVP
0.090
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4251545; hg19: chr12-44180295; COSMIC: COSV71210481; COSMIC: COSV71210481; API